Tech Company Financing Transactions
Teon Therapeutics Funding Round
Teon Therapeutics, operating out of Redwood City, raised $30 million in funding from Ocean Pine Healthcare Fund, Kaitai Capital and Lifespan Investments.
Transaction Overview
Company Name
Announced On
2/24/2021
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
Proceeds Purpose
The funds will be used to advance the company's lead A2BR-selective antagonist TT-702 into the clinic as well as to build its pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Twin Dolphin Dr. 120
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Overview
Teon Therapeutics is developing a portfolio of single-target small molecules that affect metabolic signaling pathways in the tumor microenvironment. Our pipeline consists of first-in-class and best-in-class candidates with targets that affect both immune and cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lina Yao
Chief Marketing Officer
Robert Sikorski
President
Ken Horne
Vice President
Elfatih Elzein
Vice President
Peter Fan
Vice President
James Liu
Browse more venture capital transactions:
Prev: 2/24/2021: Shippo venture capital transaction
Next: 2/24/2021: FundGuard venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs